Maple Glen, PA, United States of America

Andrew Meyer

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 89(Granted Patents)


Location History:

  • Ambler, PA (US) (2015)
  • Maple Glen, PA (US) (2008 - 2016)

Company Filing History:


Years Active: 2008-2016

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Andrew Meyer from Maple Glen, PA

Introduction: Andrew Meyer is a prominent inventor based in Maple Glen, Pennsylvania, known for his contributions to the field of biochemistry and molecular biology. With a total of seven patents to his name, Meyer has made significant strides in the development of innovative technologies aimed at modulating gene expression.

Latest Patents: One of Meyer's latest inventions is centered around bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex. This non-steroidal ligand is designed for use in a nuclear receptor-based inducible gene expression system. The invention outlines a method to control exogenous gene expression, wherein an ecdysone receptor complex comprising a DNA binding domain, a ligand binding domain, a transactivation domain, and a ligand is utilized. This innovative approach facilitates the activation or suppression of an exogenous gene, emphasizing the potential impact of his work on genetic research and therapeutic applications.

Career Highlights: Andrew Meyer is currently associated with Intrexon Corporation, a leading firm in the biotechnology sector. At Intrexon, Meyer has played a pivotal role in advancing technologies that leverage genetic engineering to address various challenges in medicine and agriculture. His work is instrumental in exploring new avenues for gene regulation and expression.

Collaborations: Throughout his career, Meyer has collaborated with esteemed colleagues such as Robert Eugene Hormann and David W Potter. These collaborations have fostered a dynamic exchange of ideas and innovations, further propelling the development of groundbreaking technologies within the company.

Conclusion: Andrew Meyer exemplifies the spirit of innovation in the field of biotechnology. His patents and collaborative efforts at Intrexon Corporation underline his commitment to advancing scientific knowledge and enhancing the capabilities of gene expression modulation. As he continues to push the boundaries of what is possible, Meyer's contributions are sure to leave a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…